<DOC>
	<DOCNO>NCT00722007</DOCNO>
	<brief_summary>The primary objective study evaluate performance Cormet Hip Resurfacing implant system post-approval environment .</brief_summary>
	<brief_title>Post PMA-Approval Study : New Enrollment Post PMA-Approval Study Post-approval Study Group ( New Enrollment )</brief_title>
	<detailed_description>This study track performance Cormet Hip Resurfacing system post-approval environment see significant change device performance pre-market IDE setting compare post-approval setting . Specifically study compare proportion subject achieve Month 24 composite clinical success ( CCS ) criterion 24 month cumulative revision rate among newly enrol post-approval study subject IDE subject ' performance CCS report Pre-Market Application ( PMA ) .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<criteria>Male female patient meet eligibility criteria consistent product label skeletally mature mentally capable complete followup form Will available followup 2 year annually thereafter last patient reach twoyear evaluation Has deem candidate hip replacement diagnosis investigator consent participate clinical study Patient active suspect infection around hip joint ; Patient bone stock inadequate support device Patient severe osteopenia Patient family history severe osteoporosis severe osteopenia ; Patient osteonecrosis avascular necrosis ( AVN ) &gt; 50 % involvement femoral head ( regardless FICAT Grade ) Patient multiple cyst femoral head ( &gt; 1cm ) In case questionable bone stock , DEXA scan may necessary ass inadequate bone stock . Patient vascular insufficiency , muscular atrophy , neuromuscular disease severe enough compromise implant stability postoperative recovery ; Female childbearing age due unknown effect fetus metal ion release . Patient known moderate severe renal insufficiency ; Patient immunosuppressed disease AIDS person receive high dos corticosteroid ; Patient severely overweight ; Patient know suspect metal sensitivity ( e.g. , jewelry ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hip resurface</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>avascular necrosis</keyword>
	<keyword>rheumatoid arthritis</keyword>
</DOC>